Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/907
Name: Drug, bio-affecting and body treating compositions > Muscular dystrophy
Description: Subject matter involving the treatment, prevention or alleviation of symptoms of muscular dystrophy.










Patents under this class:

Patent Number Title Of Patent Date Issued
8426355 Methods of treating muscular wasting diseases using NF-.kappa.B activation inhibitors Apr. 23, 2013
8334279 Non-hormonal steroid modulators of NF-.kappa.B for treatment of disease Dec. 18, 2012
8247460 Method of treatment for muscular dystrophy Aug. 21, 2012
7232580 Use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia Jun. 19, 2007
7138148 Use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia Nov. 21, 2006
6596709 6-sulphanoyl-3-quinolylphosphonic acid compounds Jul. 22, 2003
6413968 Treatment of myasthenia gravis by cyclic nucleotide phosphodiesterase inhibition Jul. 2, 2002
6261560 Method for inhibiting muscle protein proteolysis with antibodies to interleukin-6 receptor Jul. 17, 2001
6060480 Preventives/remedies for muscle tissue degenerations May. 9, 2000
5981536 Use of xanthine derivatives for the modulation of apoptosis Nov. 9, 1999
5912005 Methods of use of uncoated gel particles Jun. 15, 1999
5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin Jan. 5, 1999
5651980 Methods of use of uncoated gel particles Jul. 29, 1997
5552442 Therapeutic applications of clenbuterol Sep. 3, 1996
5541188 Therapeutic applications of beta-adrenergic agonists Jul. 30, 1996
5541074 Antibodies to dystrophin and uses therefor Jul. 30, 1996
5530029 Therapeutic applications of clenbuterol Jun. 25, 1996
5434142 Method of treatment for muscular dystrophy Jul. 18, 1995
5130141 Compositions for and methods of treating muscle degeneration and weakness Jul. 14, 1992
5070079 Pharmaceutical compositions containing cytidine monophosphate of 5-acetamido-3-, 5-D-deoxy-D-glycero-D-galacto-nonulosamic acid Dec. 3, 1991
4885167 Restoration of impaired cardiac function of patients with diverse muscular dystrophies by therapy with coenzyme Q10 Dec. 5, 1989
4741902 Compositions for treatment of neurological and related disorders May. 3, 1988
4684520 Pharmaceutical compositions having cerebral antianoxic and metabolic activities Aug. 4, 1987
4677121 Method of inhibiting muscle protein degradation Jun. 30, 1987
4418075 Epoxysuccinyl amino acid derivatives Nov. 29, 1983
4416885 Use of isopropylaminopyrimidine in the chemotherapy of muscular dystrophy, myopathy and myotonia Nov. 22, 1983
4344947 Use of isopropylaminopyrimidine in the chemotherapy of muscular dystrophy, myopathy and mytonia Aug. 17, 1982
4145421 Treating spastic conditions Mar. 20, 1979
3956374 Aryl-oxo-heptenoic acids May. 11, 1976











 
 
  Recently Added Patents
Audiovisual multi-room support
System and method for storing redundant information
Systems and methods for reducing narrow bandwidth interference contained in broad bandwidth signals
Communication apparatus, and method and program for controlling same
Content distribution system, mobile communication terminal device, and computer readable medium
Encryption using alternate authentication key
Reduced plating ignitron
  Randomly Featured Patents
Wall-hung support rail
Fibroblast growth factor-like polypeptides and variants thereof
Low cost very small aperture satellite terminal
IP packet ready PBX expansion circuit for a conventional personal computer with expandable, distributed DSP architecture
Crown form and method
Sampling system for fluidized bed gas phase polymerization reaction systems
Station wagon with adjustable rear roof panel
Methods and systems for assigning a wireless communication device to a carrier frequency
Pneumatic assembly for a paintball gun
Memory devices based on electric field programmable films